-+ 0.00%
-+ 0.00%
-+ 0.00%

Didactic, backed by GENEO Capital, buys Pearmine Health and Medadvance

PUBT·09/23/2026 07:55:01
Didactic, backed by GENEO Capital, buys Pearmine Health and Medadvance
  • Didactic acquired UK-based Pearmine Health and Germany-based Medadvance to accelerate international expansion in infectious disease prevention.
  • Pearmine adds manufacturing of wipes, impregnated gloves, oral hygiene solutions; Medadvance contributes European representation and distribution, strengthening Germany exposure.
  • Group revenue stands at EUR 90 million; headcount rises to 245 following the deal.
  • Transaction backed by long-term investors including Geneo Capital Entrepreneur and UI Investissement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geneo Capital SAS published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.